期刊文献+

弥漫性大B细胞淋巴瘤合并菌血症与肺部感染的药学监护

Pharmaceutical Care for Anti-infective Therapy in A Patient with DLBCL by Bacteremia and Lung Infection
下载PDF
导出
摘要 目的:分析肿瘤化疗患者合并感染的抗感染治疗思路。方法:以1例弥漫性大B细胞淋巴瘤(DLBCL)合并菌血症与肺部感染为例,跟踪患者治疗过程,为其制定个体化用药方案。结果:通过临床药师的用药参与,加强了用药的针对性及用药过程的监护,患者的感染症状得到了控制。结论:临床药师参与临床用药会诊,能为临床提供合理的用药方案,协助治疗,提高救治有效率。 Objective: To analyse the anti-infective treatment ideas in a tumor chemotherapy patients with infection. Methods: Through thc treatment for 1 case of diffuse large B cell lymphoma(DLBCL) complicated by bactercmia and lung infection, the whole therapeutic procedure and the therapeutic schemes were established. Results: clinical phar- macists succeeded in taking part in the treatment and reinforced the medication directed toward bacteria,the infection of the patient was controlled. Conclusion: Clinical pharmacists participated in clinical pharmacy consultations, and provid- ed the reasonable design for the clinical use of the drug to improve the successful rate of treatment.
出处 《抗感染药学》 2013年第1期65-67,共3页 Anti-infection Pharmacy
关键词 抗感染 药学监护 弥漫性大 B 细胞淋巴瘤 菌血症 anti-infection pharmaceutical care DLBCL bacteremia
  • 相关文献

参考文献4

二级参考文献11

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部